Oxytocin
Oxytocics
Vasotocin
Vasopressins
Milk Ejection
Neurophysins
Pituitary Gland, Posterior
Dinoprost
Labor, Obstetric
Ornipressin
Uterus
Pregnancy
Progesterone
Lactation
Labor, Induced
Estrus
Corpus Luteum
Hypothalamus
Luteolysis
Pregnancy, Animal
Pair Bond
Sheep
Tocolytic Agents
Hormone Antagonists
Lypressin
Endometrium
Postpartum Hemorrhage
Prostaglandins F
Labor Stage, Third
Vasopressin stimulation of acetate incorporation into lipids in a dimethylbenz(a)anthracene-induced rat mammary tumor cell line. (1/1958)
In a preliminary report we described the effects of rat prolactin on the incorporation of [14C]acetate into lipids by a cell line from a dimethylbenz(a)anthracene-induced rat mammary tumor. The characteristics of the response to prolactin were very similar to those described for the normal rat mammary gland; namely, insulin was required for full expression of the response, maximal activity was not seen until 36 hr after the addition of the hormones, and growth hormone was able to elicit the same response. However, we were unable to detect binding of 125I-labeled prolactin to these cells, and furthermore, other more purified prolactin preparations were inactive. Upon further investigation we discovered that the activity resided in a low-molecular-weight fraction of the rat prolactin B-1 preparation and was probably either vasopressin or oxytocin or both. These data suggest the possibility that vasopressin may play a role in rodent mammary tumorigenesis. (+info)Central peptidergic neurons are hyperactive during collateral sprouting and inhibition of activity suppresses sprouting. (2/1958)
Little is known regarding the effect of chronic changes in neuronal activity on the extent of collateral sprouting by identified CNS neurons. We have investigated the relationship between activity and sprouting in oxytocin (OT) and vasopressin (VP) neurons of the hypothalamic magnocellular neurosecretory system (MNS). Uninjured MNS neurons undergo a robust collateral-sprouting response that restores the axon population of the neural lobe (NL) after a lesion of the contralateral MNS (). Simultaneously, lesioned rats develop chronic urinary hyperosmolality indicative of heightened neurosecretory activity. We therefore tested the hypothesis that sprouting MNS neurons are hyperactive by measuring changes in cell and nuclear diameters, OT and VP mRNA pools, and axonal cytochrome oxidase activity (COX). Each of these measures was significantly elevated during the period of most rapid axonal growth between 1 and 4 weeks after the lesion, confirming that both OT and VP neurons are hyperactive while undergoing collateral sprouting. In a second study the hypothesis that chronic inhibition of neuronal activity would interfere with the sprouting response was tested. Chronic hyponatremia (CH) was induced 3 d before the hypothalamic lesion and sustained for 4 weeks to suppress neurosecretory activity. CH abolished the lesion-induced increases in OT and VP mRNA pools and virtually eliminated measurable COX activity in MNS terminals. Counts of the total number of axon profiles in the NL revealed that CH also prevented axonal sprouting from occurring. These results are consistent with the hypothesis that increased neuronal activity is required for denervation-induced collateral sprouting to occur in the MNS. (+info)Production of prostaglandin f2alpha and its metabolite by endometrium and yolk sac placenta in late gestation in the tammar wallaby, Macropus Eugenii. (3/1958)
In this study, we investigated production of prostaglandin (PG) F2alpha and its metabolite, PGFM, by uterine tissues from tammar wallabies in late pregnancy. Endometrial explants were prepared from gravid and nongravid uteri of tammars between Day 18 of gestation (primitive streak) and Day 26.5 (term) and were incubated in Ham's F-10 medium supplemented with glutamine and antibiotics for 20 h. PGF2alpha and PGFM in the medium were assayed by specific, validated RIAs. Control tissues (leg muscle) did not produce detectable amounts of either PG. Both gravid and nongravid endometria secreted PGF2alpha, and production increased significantly in both gravid and nongravid uteri towards term. PGFM was produced in small amounts by both gravid and nongravid uteri, and the rate of production did not increase. Neither oxytocin nor dexamethasone stimulated PG production in vitro in any tissue at any stage. Thus, the surge in peripheral plasma PGFM levels seen at parturition may arise from increased uterine PG production, but further study is needed to define what triggers this release. (+info)Down-regulation of oxytocin-induced cyclooxygenase-2 and prostaglandin F synthase expression by interferon-tau in bovine endometrial cells. (4/1958)
Oxytocin (OT) is responsible for the episodic release of luteolytic prostaglandin (PG) F2alpha from the uterus in ruminants. The attenuation of OT-stimulated uterine PGF2alpha secretion by interferon-tau (IFN-tau) is essential for prevention of luteolysis during pregnancy in cows. To better understand the mechanisms involved, the effect of recombinant bovine IFN-tau (rbIFN-tau) on OT-induced PG production and cyclooxygenase-2 (COX-2) and PGF synthase (PGFS) expression in cultured endometrial epithelial cells was investigated. Cells were obtained from cows at Days 1-3 of the estrous cycle and cultured to confluence in RPMI medium supplemented with 5% steroid-free fetal calf serum. The cells were then incubated in the presence or absence of either 100 ng/ml OT or OT+100 ng/ml rbIFN-tau for 3, 6, 12, and 24 h. OT significantly increased PGF2alpha and PGE2 secretion at all time points (p < 0.01), while rbIFN-tau inhibited the OT-induced PG production and reduced OT receptor binding in a time-dependent manner. OT increased the steady-state level of COX-2 mRNA, measured by Northern blot, which was maximal at 3 h (9-fold increase) and then decreased with time (p < 0.01). OT also caused an increase in COX-2 protein, which peaked at 12 h (11-fold increase), as measured by Western blot. Addition of rbIFN-tau suppressed the induction of COX-2 mRNA (89%, p < 0.01) and COX-2 protein (50%, p < 0.01) by OT. OT also increased PGFS mRNA, and this stimulation was attenuated by rbIFN-tau (p < 0.01). To ensure that the decrease in COX-2 was not solely due to down-regulation of the OT receptor, cells were stimulated with a phorbol ester (phorbol 12-myristate 13-acetate; PMA) in the presence and absence of rbIFN-tau. The results showed that rbIFN-tau also decreased PMA-stimulated PG production and COX-2 protein. It can be concluded that rbIFN-tau inhibition of OT-stimulated PG production is due to down-regulation of OT receptor, COX-2, and PGFS. (+info)Oxytocin and vasopressin receptors in human and uterine myomas during menstrual cycle and early pregnancy. (5/1958)
The purpose of this study was to determine the specificity and concentration of oxytocin (OT) and arginine vasopressin (AVP) binding sites in non-pregnant (NP) human and rhesus monkey endometrium, myometrium and fibromyomas, and to determine the cellular localization of OT receptor (OTR). Besides [3H]AVP, [125I]LVA, a specific VP1 receptor subtype antagonist, was used to determine vasopressin receptor (VPR) concentrations. Samples were obtained from 42 pre-menopausal and three pregnant women (5, 13 and 35 weeks gestation), and several NP and pregnant monkeys. Specificity of binding was assessed in competition experiments with unlabelled agonists and antagonists of known pharmacological potency. Cellular localization of OTR was determined by immunohistochemistry. In NP human uterine tissues, [3H]AVP was bound with higher affinity and greater binding capacity than [3H]OT, whereas in pregnant women and in NP and pregnant rhesus monkeys, uterine OT binding capacity was greater. OT and AVP binding sites discriminated very poorly between OT and AVP; [125I]LVA binding sites were more selective than [3H]AVP. Their ligand specificity and binding kinetics indicated the presence of two distinct populations of binding sites for OT and AVP in primate uterus. Endometrium of NP women and monkeys had low OTR and VPR concentrations. Myometrial and endometrial OTR and VPR were down-regulated in midcycle and in early human pregnancy, they were up-regulated in the secretory phase and second half of pregnancy. Immunoreactive OTR in NP uterus was localized in patches of myometrial muscle cells and small numbers of endometrial epithelial cells. (+info)Desensitization of oxytocin receptors in human myometrium. (6/1958)
In the present study, we investigated the possible mechanisms by which oxytocin might regulate oxytocin receptor (OTR) density. Exposure of cultured myometrial cells to oxytocin for a prolonged period caused desensitization: the steady-state level of oxytocin binding was 210 x 10(3) binding sites/cell, but this was time-dependently reduced to 20.1 x 10(3) sites/cell by exposing the cells to oxytocin for up to 20 h. In contrast, Western blotting data showed that the total amount of OTR protein was not affected by oxytocin treatment for up to 24 h. Flow cytometry experiments demonstrated that OTRs were not internalized during this treatment. However, RNase protection assays and Northern analysis showed that in cultured myometrial cells OTR mRNA was reduced by oxytocin treatment to reach a new low steady-state concentration. Analysis of this mRNA in myometrial biopsies from 17 patients undergoing emergency Caesarean section showed how it decreased with advancing labour. Samples obtained after 12 h of labour contained approximately 50 times less OTR mRNA than samples obtained from patients in labour for less than 12 h. We speculate that this decrease in OTR mRNA represents in-vivo OTR desensitization. (+info)Uterine peristalsis during the follicular phase of the menstrual cycle: effects of oestrogen, antioestrogen and oxytocin. (7/1958)
Uterine peristalsis, directing sustained and rapid sperm transport from the external cervical os or the cervical crypts to the isthmic part of the tube ipsilateral to the dominant follicle, changes in direction and frequency during the menstrual cycle, with lowest activity during menstruation and highest activity at mid cycle. It was therefore suggested that uterine peristalsis is under the control of the dominant follicle with the additional involvement of oxytocin. To test this hypothesis, vaginal sonography of uterine peristalsis was performed in the early, mid and late proliferative phases, respectively, of cycles of women treated with oestradiol valerate and with human menopausal gonadotrophin following pituitary downregulation, with clomiphene citrate and with intravenous oxytocin, respectively. Administration of oestradiol valerate resulted in oestradiol serum concentrations comparable with the normal cycle with a simulation of the normal frequency of peristaltic contractions. Elevated oestradiol concentrations and bolus injections of oxytocin resulted in a significant increase in the frequency of peristaltic contractions in the early and mid follicular phases, respectively. Chlomiphene tended, though insignificantly so, to suppress the frequency of peristaltic waves in the presence of elevated oestradiol concentrations. In the late follicular phase of the cycle extremely elevated oestradiol concentrations as well as the injection of oxytocin resulted only in an insignificant further increase of peristaltic frequency. In the normal cycles, as well as during extremely elevated oestradiol concentrations and following oxytocin administration, the peristaltic contractions were always confined to the subendometrial layer of the muscular wall. The results and the review of literature indicate that uterine peristalsis during the follicular phase of the menstrual cycle is controlled by oestradiol released from the dominant follicle with the probable involvement of oxytocin, which is presumably stimulated together with its receptor within the endometrial-subendometrial unit and therefore acting in an autocrine/paracrine fashion. Since unphysiological stimulation with oestradiol and oxytocin did not significantly increase the frequency of uterine peristalsis in the late follicular phase of the cycle it is assumed that normal preovulatory frequency of uterine peristalsis is at a level which cannot be significantly surpassed due to phenomena of refractoriness of the system. (+info)Sperm transport in the human female genital tract and its modulation by oxytocin as assessed by hysterosalpingoscintigraphy, hysterotonography, electrohysterography and Doppler sonography. (8/1958)
The transport function of the uterus and oviducts and its modulation by oxytocin has been examined using hysterosalpingoscintigraphy, recording of intrauterine pressure, electrohysterography and Doppler sonography of the Fallopian tubes. After application to the posterior vaginal fornix, a rapid (within minutes) uptake of the labelled particles into the uterus was observed during the follicular and during the luteal phase of the cycle in all patients. Transport into the oviducts, however, could only be demonstrated during the follicular phase. Transport was directed predominantly into the tube ipsilateral to the ovary bearing the dominant follicle; the contralateral oviduct appeared to be functionally closed. The proportion of patients exhibiting ipsilateral transport did increase concomitant with the increase of the diameter of the dominant follicle. That ipsilateral transport has biological significance is suggested by the observation that the pregnancy rate following spontaneous intercourse or insemination was significantly higher in those women in whom ipsilateral transport could be demonstrated than in those who failed to exhibit lateralization. Oxytocin administration was followed by a dramatic increase in the amount of material transported to the ipsilateral tube, as demonstrated by radionuclide imaging and by Doppler sonography following instillation of ultrasound contrast medium. Continuous recording of intrauterine pressure before and after oxytocin administration did show an increase in basal tonus and amplitude of contractions and a reversal of the pressure gradient from a fundo-cervical to a cervico-fundal direction. These actions of oxytocin were accompanied by an increase in amplitude of potentials recorded by electrohysterography. These data support the view that uterus and Fallopian tubes represent a functional unit that is acting as a peristaltic pump and that the increasing activity of this pump during the follicular phase of the menstrual cycle is reflected by an increased transport into the oviduct ipsilateral to the ovary bearing the dominant follicle. In addition, they strongly suggest a critical role of oxytocin in this process. Failure of this mechanism appears to be a cause of subfertility or infertility, as indicated by the low pregnancy rate following intrauterine insemination or normal intercourse in the presence of patent Fallopian tubes. It may be regarded as a new nosological entity for which we propose the term tubal transport disorder (TTD). Since pregnancy rate of such patients is normal when treated with in-vitro fertilization (IVF), hysterosalpingoscintigraphy seems to be useful for the choice of treatment modalities in patients with patent Fallopian tubes suffering from infertility. (+info)Oxytocin is a hormone that is produced in the hypothalamus and released by the posterior pituitary gland. It plays a crucial role in various physiological processes, including social bonding, childbirth, and breastfeeding. During childbirth, oxytocin stimulates uterine contractions to facilitate labor and delivery. After giving birth, oxytocin continues to be released in large amounts during breastfeeding, promoting milk letdown and contributing to the development of the maternal-infant bond.
In social contexts, oxytocin has been referred to as the "love hormone" or "cuddle hormone," as it is involved in social bonding, trust, and attachment. It can be released during physical touch, such as hugging or cuddling, and may contribute to feelings of warmth and closeness between individuals.
In addition to its roles in childbirth, breastfeeding, and social bonding, oxytocin has been implicated in other physiological functions, including regulating blood pressure, reducing anxiety, and modulating pain perception.
Oxytocics are a class of medications that stimulate the contraction of uterine smooth muscle. They are primarily used in obstetrics to induce or augment labor, and to control bleeding after childbirth. Oxytocin is the most commonly used oxytocic and is naturally produced by the posterior pituitary gland. Synthetic forms of oxytocin, such as Pitocin, are often used in medical settings to induce labor or reduce postpartum bleeding. Other medications with oxytocic properties include ergometrine and methylergometrine. It's important to note that the use of oxytocics should be monitored carefully as overuse can lead to excessive uterine contractions, which may compromise fetal oxygenation and increase the risk of uterine rupture.
Vasotocin is not generally recognized as a medical term or a well-established physiological concept in human medicine. However, it is a term used in comparative endocrinology and animal physiology to refer to a nonapeptide hormone that is functionally and structurally similar to arginine vasopressin (AVP) or antidiuretic hormone (ADH) in mammals.
Vasotocin is found in various non-mammalian vertebrates, including fish, amphibians, and reptiles, where it plays roles in regulating water balance, blood pressure, social behaviors, and reproduction. In these animals, vasotocin is produced by the hypothalamus and stored in the posterior pituitary gland before being released into the circulation to exert its effects on target organs.
Therefore, while not a medical definition per se, vasotocin can be defined as a neuropeptide hormone that regulates various physiological functions in non-mammalian vertebrates, with structural and functional similarities to mammalian arginine vasopressin.
Vasopressin, also known as antidiuretic hormone (ADH), is a hormone that helps regulate water balance in the body. It is produced by the hypothalamus and stored in the posterior pituitary gland. When the body is dehydrated or experiencing low blood pressure, vasopressin is released into the bloodstream, where it causes the kidneys to decrease the amount of urine they produce and helps to constrict blood vessels, thereby increasing blood pressure. This helps to maintain adequate fluid volume in the body and ensure that vital organs receive an adequate supply of oxygen-rich blood. In addition to its role in water balance and blood pressure regulation, vasopressin also plays a role in social behaviors such as pair bonding and trust.
Medical definition: "Milk ejection," also known as the "let-down reflex," is the release of milk from the alveoli (milk-producing sacs) of the breast during breastfeeding or pumping. It occurs when the hormone oxytocin is released into the bloodstream, causing the smooth muscles surrounding the alveoli to contract and push out the milk. This reflex is an essential part of lactation and helps ensure that the baby receives enough milk during feeding. The milk ejection can be triggered by various stimuli such as suckling, thinking about or hearing the baby, or physical touch.
The supraoptic nucleus (SON) is a collection of neurons located in the hypothalamus, near the optic chiasm, in the brain. It plays a crucial role in regulating osmoregulation and fluid balance within the body through the production and release of vasopressin, also known as antidiuretic hormone (ADH).
Vasopressin is released into the bloodstream and acts on the kidneys to promote water reabsorption, thereby helping to maintain normal blood pressure and osmolarity. The supraoptic nucleus receives input from osmoreceptors in the circumventricular organs of the brain, which detect changes in the concentration of solutes in the extracellular fluid. When the osmolarity increases, such as during dehydration, the supraoptic nucleus is activated to release vasopressin and help restore normal fluid balance.
Additionally, the supraoptic nucleus also contains oxytocin-producing neurons, which play a role in social bonding, maternal behavior, and childbirth. Oxytocin is released into the bloodstream and acts on various tissues, including the uterus and mammary glands, to promote contraction and milk ejection.
Neurophysins are small protein molecules that are derived from the larger precursor protein, pro-neurophysin. They are synthesized in the hypothalamus of the brain and are stored in and released from neurosecretory granules, along with neurohypophysial hormones such as oxytocin and vasopressin.
Neurophysins serve as carrier proteins for these hormones, helping to stabilize them and facilitate their transport and release into the bloodstream. There are two main types of neurophysins, neurophysin I and neurophysin II, which are associated with oxytocin and vasopressin, respectively.
Neurophysins have been studied for their potential role in various physiological processes, including water balance, social behavior, and reproductive functions. However, their precise mechanisms of action and functional significance are still not fully understood.
The posterior pituitary gland, also known as the neurohypophysis, is the posterior portion of the pituitary gland. It is primarily composed of nerve fibers that originate from the hypothalamus, a region of the brain. These nerve fibers release two important hormones: oxytocin and vasopressin (also known as antidiuretic hormone or ADH).
Oxytocin plays a role in social bonding, sexual reproduction, and childbirth. During childbirth, it stimulates uterine contractions to help facilitate delivery, and after birth, it helps to trigger the release of milk from the mother's breasts during breastfeeding.
Vasopressin, on the other hand, helps regulate water balance in the body by controlling the amount of water that is excreted by the kidneys. It does this by increasing the reabsorption of water in the collecting ducts of the kidney, which leads to a more concentrated urine and helps prevent dehydration.
Overall, the posterior pituitary gland plays a critical role in maintaining fluid balance, social bonding, and reproduction.
A uterine contraction is a rhythmic, involuntary muscle tightening that occurs in the uterus. These contractions are primarily caused by the activation of smooth muscle cells within the uterine wall, known as myometrial cells. They play a crucial role in various reproductive processes, including menstruation, implantation of a fertilized egg, and childbirth (labor).
During labor, strong and frequent uterine contractions help to dilate the cervix and efface (thin) the lower part of the uterus. As the contractions become more intense and regular, they assist in moving the baby down through the birth canal, ultimately resulting in delivery. Uterine contractions are regulated by a complex interplay of hormones, neurotransmitters, and other signaling molecules, ensuring proper coordination and timing throughout the reproductive process.
The myometrium is the middle and thickest layer of the uterine wall, composed mainly of smooth muscle cells. It is responsible for the strong contractions during labor and can also contribute to bleeding during menstruation or childbirth. The myometrium is able to stretch and expand to accommodate a growing fetus and then contract during labor to help push the baby out. It also plays a role in maintaining the structure and shape of the uterus, and in protecting the internal organs within the pelvic cavity.
Dinoprost is a synthetic form of prostaglandin F2α, which is a naturally occurring hormone-like substance in the body. It is used in veterinary medicine as a uterotonic agent to induce labor and abortion in various animals such as cows and pigs. In human medicine, it may be used off-label for similar purposes, but its use must be under the close supervision of a healthcare provider due to potential side effects and risks.
It is important to note that Dinoprost is not approved by the FDA for use in humans, and its availability may vary depending on the country or region. Always consult with a licensed healthcare professional before using any medication, including Dinoprost.
'Labor, Obstetric' refers to the physiological process that occurs during childbirth, leading to the expulsion of the fetus from the uterus. It is divided into three stages:
1. The first stage begins with the onset of regular contractions and cervical dilation and effacement (thinning and shortening) until full dilation is reached (approximately 10 cm). This stage can last from hours to days, particularly in nulliparous women (those who have not given birth before).
2. The second stage starts with complete cervical dilation and ends with the delivery of the baby. During this stage, the mother experiences strong contractions that help push the fetus down the birth canal. This stage typically lasts from 20 minutes to two hours but can take longer in some cases.
3. The third stage involves the delivery of the placenta (afterbirth) and membranes, which usually occurs within 15-30 minutes after the baby's birth. However, it can sometimes take up to an hour for the placenta to be expelled completely.
Obstetric labor is a complex process that requires careful monitoring and management by healthcare professionals to ensure the safety and well-being of both the mother and the baby.
Ornipressin is not a commonly used medication in modern clinical practice, and it's possible that you may be referring to desmopressin, which is an analog of the natural hormone vasopressin. Here is the definition for desmopressin:
Desmopressin: A synthetic analog of the natural hormone arginine vasopressin, used as a nasal spray, injection, or tablet to treat diabetes insipidus (a condition in which the kidneys can't regulate the body's water balance) and von Willebrand disease (a genetic disorder that affects blood clotting). It works by decreasing the amount of urine produced by the kidneys, increasing the concentration of certain substances in the urine, and helping the blood to clot. Desmopressin is also used off-label for the treatment of nocturnal enuresis (bedwetting) in children.
The uterus, also known as the womb, is a hollow, muscular organ located in the female pelvic cavity, between the bladder and the rectum. It has a thick, middle layer called the myometrium, which is composed of smooth muscle tissue, and an inner lining called the endometrium, which provides a nurturing environment for the fertilized egg to develop into a fetus during pregnancy.
The uterus is where the baby grows and develops until it is ready for birth through the cervix, which is the lower, narrow part of the uterus that opens into the vagina. The uterus plays a critical role in the menstrual cycle as well, by shedding its lining each month if pregnancy does not occur.
Pregnancy is a physiological state or condition where a fertilized egg (zygote) successfully implants and grows in the uterus of a woman, leading to the development of an embryo and finally a fetus. This process typically spans approximately 40 weeks, divided into three trimesters, and culminates in childbirth. Throughout this period, numerous hormonal and physical changes occur to support the growing offspring, including uterine enlargement, breast development, and various maternal adaptations to ensure the fetus's optimal growth and well-being.
The Paraventricular Hypothalamic Nucleus (PVN) is a nucleus in the hypothalamus, which is a part of the brain that regulates various autonomic functions and homeostatic processes. The PVN plays a crucial role in the regulation of neuroendocrine and autonomic responses to stress, as well as the control of fluid and electrolyte balance, cardiovascular function, and energy balance.
The PVN is composed of several subdivisions, including the magnocellular and parvocellular divisions. The magnocellular neurons produce and release two neuropeptides, oxytocin and vasopressin (also known as antidiuretic hormone), into the circulation via the posterior pituitary gland. These neuropeptides play important roles in social behavior, reproduction, and fluid balance.
The parvocellular neurons, on the other hand, project to various brain regions and the pituitary gland, where they release neurotransmitters and neuropeptides that regulate the hypothalamic-pituitary-adrenal (HPA) axis, which is responsible for the stress response. The PVN also contains neurons that produce corticotropin-releasing hormone (CRH), a key neurotransmitter involved in the regulation of the HPA axis and the stress response.
Overall, the Paraventricular Hypothalamic Nucleus is an essential component of the brain's regulatory systems that help maintain homeostasis and respond to stressors. Dysfunction of the PVN has been implicated in various pathological conditions, including hypertension, obesity, and mood disorders.
Progesterone is a steroid hormone that is primarily produced in the ovaries during the menstrual cycle and in pregnancy. It plays an essential role in preparing the uterus for implantation of a fertilized egg and maintaining the early stages of pregnancy. Progesterone works to thicken the lining of the uterus, creating a nurturing environment for the developing embryo.
During the menstrual cycle, progesterone is produced by the corpus luteum, a temporary structure formed in the ovary after an egg has been released from a follicle during ovulation. If pregnancy does not occur, the levels of progesterone will decrease, leading to the shedding of the uterine lining and menstruation.
In addition to its reproductive functions, progesterone also has various other effects on the body, such as helping to regulate the immune system, supporting bone health, and potentially influencing mood and cognition. Progesterone can be administered medically in the form of oral pills, intramuscular injections, or vaginal suppositories for various purposes, including hormone replacement therapy, contraception, and managing certain gynecological conditions.
Lactation is the process by which milk is produced and secreted from the mammary glands of female mammals, including humans, for the nourishment of their young. This physiological function is initiated during pregnancy and continues until it is deliberately stopped or weaned off. The primary purpose of lactation is to provide essential nutrients, antibodies, and other bioactive components that support the growth, development, and immune system of newborns and infants.
The process of lactation involves several hormonal and physiological changes in a woman's body. During pregnancy, the hormones estrogen and progesterone stimulate the growth and development of the mammary glands. After childbirth, the levels of these hormones drop significantly, allowing another hormone called prolactin to take over. Prolactin is responsible for triggering the production of milk in the alveoli, which are tiny sacs within the breast tissue.
Another hormone, oxytocin, plays a crucial role in the release or "let-down" of milk from the alveoli to the nipple during lactation. This reflex is initiated by suckling or thinking about the baby, which sends signals to the brain to release oxytocin. The released oxytocin then binds to receptors in the mammary glands, causing the smooth muscles around the alveoli to contract and push out the milk through the ducts and into the nipple.
Lactation is a complex and highly regulated process that ensures the optimal growth and development of newborns and infants. It provides not only essential nutrients but also various bioactive components, such as immunoglobulins, enzymes, and growth factors, which protect the infant from infections and support their immune system.
In summary, lactation is the physiological process by which milk is produced and secreted from the mammary glands of female mammals for the nourishment of their young. It involves hormonal changes, including the actions of prolactin, oxytocin, estrogen, and progesterone, to regulate the production, storage, and release of milk.
Induced labor refers to the initiation of labor before it begins spontaneously, which is usually achieved through medical intervention. This process is initiated when there is a medically indicated reason to deliver the baby, such as maternal or fetal compromise, prolonged pregnancy, or reduced fetal movement. The most common methods used to induce labor include membrane stripping, prostaglandin administration, and oxytocin infusion. It's important to note that induced labor carries certain risks, including a higher chance of uterine hyperstimulation, infection, and the need for assisted vaginal delivery or cesarean section. Therefore, it should only be performed under the close supervision of a healthcare provider in a clinical setting.
Estrus is a term used in veterinary medicine to describe the physiological and behavioral state of female mammals that are ready to mate and conceive. It refers to the period of time when the female's reproductive system is most receptive to fertilization.
During estrus, the female's ovaries release one or more mature eggs (ovulation) into the fallopian tubes, where they can be fertilized by sperm from a male. This phase of the estrous cycle is often accompanied by changes in behavior and physical appearance, such as increased vocalization, restlessness, and swelling of the genital area.
The duration and frequency of estrus vary widely among different species of mammals. In some animals, such as dogs and cats, estrus occurs regularly at intervals of several weeks or months, while in others, such as cows and mares, it may only occur once or twice a year.
It's important to note that the term "estrus" is not used to describe human reproductive physiology. In humans, the equivalent phase of the menstrual cycle is called ovulation.
The corpus luteum is a temporary endocrine structure that forms in the ovary after an oocyte (egg) has been released from a follicle during ovulation. It's formed by the remaining cells of the ruptured follicle, which transform into large, hormone-secreting cells.
The primary function of the corpus luteum is to produce progesterone and, to a lesser extent, estrogen during the menstrual cycle or pregnancy. Progesterone plays a crucial role in preparing the uterus for potential implantation of a fertilized egg and maintaining the early stages of pregnancy. If pregnancy does not occur, the corpus luteum will typically degenerate and stop producing hormones after approximately 10-14 days, leading to menstruation.
However, if pregnancy occurs, the developing embryo starts to produce human chorionic gonadotropin (hCG), which signals the corpus luteum to continue secreting progesterone and estrogen until the placenta takes over hormonal production, usually around the end of the first trimester.
The hypothalamus is a small, vital region of the brain that lies just below the thalamus and forms part of the limbic system. It plays a crucial role in many important functions including:
1. Regulation of body temperature, hunger, thirst, fatigue, sleep, and circadian rhythms.
2. Production and regulation of hormones through its connection with the pituitary gland (the hypophysis). It controls the release of various hormones by producing releasing and inhibiting factors that regulate the anterior pituitary's function.
3. Emotional responses, behavior, and memory formation through its connections with the limbic system structures like the amygdala and hippocampus.
4. Autonomic nervous system regulation, which controls involuntary physiological functions such as heart rate, blood pressure, and digestion.
5. Regulation of the immune system by interacting with the autonomic nervous system.
Damage to the hypothalamus can lead to various disorders like diabetes insipidus, growth hormone deficiency, altered temperature regulation, sleep disturbances, and emotional or behavioral changes.
Luteolysis is the physiological process that leads to the breakdown and regression of the corpus luteum, a temporary endocrine structure in the ovary that forms after ovulation. The corpus luteum produces progesterone, which supports pregnancy in mammals. If pregnancy does not occur, luteolysis takes place approximately 10-14 days after ovulation in humans and is characterized by the degeneration of the corpus luteum, decreased production of progesterone, and the initiation of the menstrual cycle or the onset of a new reproductive cycle.
The primary event that triggers luteolysis is the release of prostaglandin F2α (PGF2α) from the uterus, which reaches the corpus luteum through the systemic circulation and causes vasoconstriction, reduced blood flow, and structural damage to the corpus luteum. This results in a decline in progesterone levels, which ultimately leads to menstruation or the onset of a new reproductive cycle.
In summary, luteolysis is a crucial process in the female reproductive system that regulates hormonal balance and prepares the body for a new reproductive cycle when pregnancy does not occur.
Maternal behavior refers to the nurturing and protective behaviors exhibited by a female animal towards its offspring. In humans, this term is often used to describe the natural instincts and actions of a woman during pregnancy, childbirth, and early child-rearing. It encompasses a broad range of activities such as feeding, grooming, protecting, and teaching the young.
In the context of medical and psychological research, maternal behavior is often studied to understand the factors that influence its development, expression, and outcomes for both the mother and offspring. Factors that can affect maternal behavior include hormonal changes during pregnancy and childbirth, as well as social, cultural, and environmental influences.
Abnormal or atypical maternal behavior may indicate underlying mental health issues, such as postpartum depression or anxiety, and can have negative consequences for both the mother and the child's development and well-being. Therefore, it is important to monitor and support healthy maternal behaviors in new mothers to promote positive outcomes for both parties.
"Animal pregnancy" is not a term that is typically used in medical definitions. However, in biological terms, animal pregnancy refers to the condition where a fertilized egg (or eggs) implants and develops inside the reproductive tract of a female animal, leading to the birth of offspring (live young).
The specific details of animal pregnancy can vary widely between different species, with some animals exhibiting phenomena such as placental development, gestation periods, and hormonal changes that are similar to human pregnancy, while others may have very different reproductive strategies.
It's worth noting that the study of animal pregnancy and reproduction is an important area of biological research, as it can provide insights into fundamental mechanisms of embryonic development, genetics, and evolution.
A pair bond, in the context of human and animal behavior, refers to a long-term emotional and social attachment between two individuals, usually characterized by a strong affection, shared activities, and often sexual interaction. In humans, this concept is often discussed in the context of romantic relationships and marriage. From a medical or scientific perspective, pair bonding involves neurological and hormonal processes that help to create and maintain the attachment, such as the release of oxytocin and vasopressin during physical touch and sexual activity. The strength and duration of pair bonds can vary widely between different species and individuals.
Social behavior, in the context of medicine and psychology, refers to the ways in which individuals interact and engage with others within their social environment. It involves various actions, communications, and responses that are influenced by cultural norms, personal values, emotional states, and cognitive processes. These behaviors can include but are not limited to communication, cooperation, competition, empathy, altruism, aggression, and conformity.
Abnormalities in social behavior may indicate underlying mental health conditions such as autism spectrum disorder, schizophrenia, or personality disorders. Therefore, understanding and analyzing social behavior is an essential aspect of diagnosing and treating various psychological and psychiatric conditions.
I apologize, but "sheep" is not a term that has a medical definition. It is a common animal with the scientific name Ovis aries. If you have any medical or health-related questions, I would be happy to try and help answer those for you.
Tocolytic agents are a type of medication used in obstetrics to suppress premature labor. They work by relaxing the smooth muscle of the uterus, thereby reducing contractions and delaying delivery. Commonly used tocolytic agents include beta-adrenergic agonists (such as terbutaline), calcium channel blockers (such as nifedipine), and prostaglandin synthesis inhibitors (such as indomethacin). It's important to note that the use of tocolytic agents is typically reserved for specific clinical situations, and their benefits must be weighed against potential risks to both the mother and fetus.
Hormone antagonists are substances or drugs that block the action of hormones by binding to their receptors without activating them, thereby preventing the hormones from exerting their effects. They can be classified into two types: receptor antagonists and enzyme inhibitors. Receptor antagonists bind directly to hormone receptors and prevent the hormone from binding, while enzyme inhibitors block the production or breakdown of hormones by inhibiting specific enzymes involved in their metabolism. Hormone antagonists are used in the treatment of various medical conditions, such as cancer, hormonal disorders, and cardiovascular diseases.
Lypressin is a synthetic analogue of a natural hormone called vasopressin, which is produced by the pituitary gland in the brain. The primary function of vasopressin, also known as antidiuretic hormone (ADH), is to regulate water balance in the body by controlling the amount of urine produced by the kidneys.
Lypressin has similar physiological effects to vasopressin and is used in medical treatments for conditions related to the regulation of water balance, such as diabetes insipidus. Diabetes insipidus is a condition characterized by excessive thirst and the production of large amounts of dilute urine due to a deficiency in vasopressin or an impaired response to it.
In summary, Lypressin is a synthetic form of vasopressin, a hormone that helps regulate water balance in the body by controlling urine production in the kidneys. It is used as a therapeutic agent for treating diabetes insipidus and related conditions.
The endometrium is the innermost layer of the uterus, which lines the uterine cavity and has a critical role in the menstrual cycle and pregnancy. It is composed of glands and blood vessels that undergo cyclic changes under the influence of hormones, primarily estrogen and progesterone. During the menstrual cycle, the endometrium thickens in preparation for a potential pregnancy. If fertilization does not occur, it will break down and be shed, resulting in menstruation. In contrast, if implantation takes place, the endometrium provides essential nutrients to support the developing embryo and placenta throughout pregnancy.
Postpartum hemorrhage (PPH) is a significant obstetrical complication defined as the loss of more than 500 milliliters of blood within the first 24 hours after childbirth, whether it occurs vaginally or through cesarean section. It can also be defined as a blood loss of more than 1000 mL in relation to the amount of blood lost during the procedure and the patient's baseline hematocrit level.
Postpartum hemorrhage is classified into two types: primary (early) PPH, which occurs within the first 24 hours after delivery, and secondary (late) PPH, which happens between 24 hours and 12 weeks postpartum. The most common causes of PPH are uterine atony, trauma to the genital tract, retained placental tissue, and coagulopathy.
Uterine atony is the inability of the uterus to contract effectively after delivery, leading to excessive bleeding. Trauma to the genital tract can occur during childbirth, causing lacerations or tears that may result in bleeding. Retained placental tissue refers to the remnants of the placenta left inside the uterus, which can cause infection and heavy bleeding. Coagulopathy is a condition where the blood has difficulty clotting, leading to uncontrolled bleeding.
Symptoms of PPH include excessive vaginal bleeding, low blood pressure, increased heart rate, decreased urine output, and signs of shock such as confusion, rapid breathing, and pale skin. Treatment for PPH includes uterotonics, manual removal of retained placental tissue, repair of genital tract lacerations, blood transfusions, and surgery if necessary.
Preventing PPH involves proper antenatal care, monitoring high-risk pregnancies, active management of the third stage of labor, and prompt recognition and treatment of any bleeding complications during or after delivery.
Prostaglandin F (PGF) is a type of prostaglandin, which is a group of lipid compounds that are synthesized in the body from fatty acids and have diverse hormone-like effects. Prostaglandin F is a naturally occurring compound that is produced in various tissues throughout the body, including the uterus, lungs, and kidneys.
There are two major types of prostaglandin F: PGF1α and PGF2α. These compounds play important roles in a variety of physiological processes, including:
* Uterine contraction: Prostaglandin F helps to stimulate uterine contractions during labor and childbirth. It is also involved in the shedding of the uterine lining during menstruation.
* Bronchodilation: In the lungs, prostaglandin F can help to relax bronchial smooth muscle and promote bronchodilation.
* Renal function: Prostaglandin F helps to regulate blood flow and fluid balance in the kidneys.
Prostaglandin F is also used as a medication to induce labor, treat postpartum hemorrhage, and manage some types of glaucoma. It is available in various forms, including injections, tablets, and eye drops.
The third stage of labor is the period between the delivery of the baby and the expulsion of the placenta. It is also known as the afterbirth stage. This stage is typically completed within 5-30 minutes, but can take up to an hour. During this stage, the uterus continues to contract, causing the separation of the placenta from the uterine wall. Once separated, the placenta is expelled from the body with the help of contractions and a strong push from the mother. It is important for medical professionals to monitor this stage closely to ensure that the entire placenta is expelled and to manage any potential complications, such as heavy bleeding.
Uterine inertia is a medical condition that occurs during childbirth, specifically during the second stage of labor. It is defined as the failure of the uterus to contract efficiently and effectively during this stage, leading to prolonged or arrested labor. This can result in complications for both the mother and the baby, such as fetal distress, postpartum hemorrhage, and infection. Uterine inertia can be caused by various factors, including exhaustion of the uterus, drugs that interfere with muscle contractions, or abnormalities in the uterus itself. Treatment typically involves administering oxytocin to stimulate stronger contractions, assisted delivery methods such as forceps or vacuum extraction, or in some cases, cesarean section.